Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis.Int J Epidemiol. 2014; 43: 434-442
- Prevalence and characteristics of autism spectrum disorder among children aged 8 years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.MMWR Surveill Summ. 2016; 65: 1-23
- Diagnostic and Statistical Manual of Mental Disorders.5th ed. American Psychiatric Publishing, Arlington, VA2013
- Meta-analysis of the heritability of human traits based on fifty years of twin studies.Nat Genet. 2015; 47: 702-709
- Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.Nat Genet. 2019; 51: 63-75
- Identification of common genetic risk variants for autism spectrum disorder.Nat Genet. 2019; 51: 431-444
- Long-range enhancer–promoter contacts in gene expression control.Nat Rev Genet. 2019; 20: 437-455
- Quantifying the mapping precision of genome-wide association studies using whole-genome sequencing data.Genome Biol. 2017; 18: 86
- Linking disease associations with regulatory information in the human genome.Genome Res. 2012; 22: 1748-1759
- Mapping and analysis of chromatin state dynamics in nine human cell types.Nature. 2011; 473: 43-49
- Systematic localization of common disease-associated variation in regulatory DNA.Science. 2012; 337: 1190-1195
- The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts.Genome Biol. 2014; 15: R37
- Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci.Nat Neurosci. 2016; 19: 48-54
- Multiple epigenetic factors predict the attention deficit/hyperactivity disorder among the Chinese Han children.J Psychiatr Res. 2015; 64: 40-50
- Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder.Epigenomics. 2016; 8: 85-104
- Epigenetics of autism spectrum disorders.Hum Mol Genet. 2006; 15: R138-R150
- Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder.Eur Child Adolesc Psychiatry. 2010; 19: 281-295
- Sibling recurrence risk and cross-aggregation of attention-deficit/hyperactivity disorder and autism spectrum disorder.JAMA Pediatr. 2019; 173: 147-152
- The familial co-aggregation of ASD and ADHD: A register-based cohort study.Mol Psychiatry. 2018; 23: 257-262
- Shared familial transmission of autism spectrum and attention-deficit/hyperactivity disorders.J Child Psychol Psychiatry. 2014; 55: 819-827
- Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: Evidence from copy number variants.J Am Acad Child Adolesc Psychiatry. 2014; 53: 761-770.e26
- Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.Nat Genet. 2016; 48: 481-487
- Pleiotropic effects of trait-associated genetic variation on DNA methylation: Utility for refining GWAS loci.Am J Hum Genet. 2017; 100: 954-959
- Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits.Nat Commun. 2018; 9: 918
- Genomic insights into the overlap between psychiatric disorders: Implications for research and clinical practice.Genome Med. 2014; 6: 29
- Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders.Cell. 2019; 177: 162-183
- Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders.Genome Biol. 2018; 19: 194
- Methylomic trajectories across human fetal brain development.Genome Res. 2015; 25: 338-352
- Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood.Nat Commun. 2018; 9: 2282
- Cohort profile: The Health and Retirement Study (HRS).Int J Epidemiol. 2014; 43: 576-585
- An integrated map of genetic variation from 1,092 human genomes.Nature. 2012; 491: 56-65
- Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits.Nat Genet. 2019; 51: 933-940
- Transcriptome-wide association study of attention deficit hyperactivity disorder identifies associated genes and phenotypes.Nat Commun. 2019; 10: 4450
- Prediction of causal genes and gene expression analysis of attention-deficit hyperactivity disorder in the different brain region, a comprehensive integrative analysis of ADHD.Behav Brain Res. 2019; 364: 183-192
- Synergistic effects of common schizophrenia risk variants.Nat Genet. 2019; 51: 1475-1485
- Evolutionary toggling of the MAPT 17q21.31 inversion region.Nat Genet. 2008; 40: 1076-1083
- Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome.Nat Genet. 2012; 44: 639-641
- The H1c haplotype at the MAPT locus is associated with Alzheimer’s disease.Hum Mol Genet. 2005; 14: 2399-2404
- Dissection of the genetics of Parkinson’s disease identifies an additional association 5’ of SNCA and multiple associated haplotypes at 17q21.Hum Mol Genet. 2011; 20: 345-353
- Family based genome-wide copy number scan identifies complex rearrangements at 17q21.31 in dyslexics.Am J Med Genet B Neuropsychiatr Genet. 2014; 165B: 572-580
- Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.Nat Genet. 2016; 48: 624-633
- Common variants at 6q22 and 17q21 are associated with intracranial volume.Nat Genet. 2012; 44: 539-544
- Novel insight into the etiology of autism spectrum disorder gained by integrating expression data with genome-wide association statistics.Biol Psychiatry. 2019; 86: 265-273
- Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder.Science. 2018; 362eaat8127
- Deciphering the emerging complexities of molecular mechanisms at GWAS loci.Am J Hum Genet. 2018; 103: 637-653
eQTLGen Consortium (Author list is ordered alphabetically):
Mawussé Agbessi1, Habibul Ahsan2, Isabel Alves1, Anand Andiappan3, Wibowo Arindrarto4, Philip Awadalla1, Alexis Battle5,6, Frank Beutner7, Marc Jan Bonder8,9,10, Dorret I Boomsma11, Mark Christiansen12, Annique Claringbould8, Patrick Deelen8,13, Tõnu Esko14, Marie-Julie Favé1, Lude Franke8, Timothy Frayling15, Sina A. Gharib16,12, Gregory Gibson17, Bastiaan T. Heijmans4, Gibran Hemani18, Rick Jansen19, Mika Kähönen20, Anette Kalnapenkis14, Silva Kasela14, Johannes Kettunen21, Yungil Kim6,22, Holger Kirsten23, Peter Kovacs24, Knut Krohn25, Jaanika Kronberg-Guzman14, Viktorija Kukushkina14, Zoltan Kutalik26, Bernett Lee3, Terho Lehtimäki27, Markus Loeffler23, Urko M. Marigorta17, Hailang Mei4, Lili Milani14, Grant W. Montgomery28, Martina Müller-Nurasyid29,30,31, Matthias Nauck32,33, Michel Nivard11, Brenda Penninx19, Markus Perola34, Natalia Pervjakova14, Brandon L. Pierce2, Joseph Powell35, Holger Prokisch36,37, Bruce M. Psaty12,38,39, Olli T. Raitakari40, Samuli Ripatti41, Olaf Rotzschke3, Sina Rüeger26, Ashis Saha6, Markus Scholz23, Katharina Schramm29,30,31, Ilkka Seppälä27, Eline P. Slagboom4, Coen D.A. Stehouwer42, Michael Stumvoll43, Patrick Sullivan44, Peter A.C. ‘t Hoen45, Alexander Teumer46, Joachim Thiery47, Lin Tong2, Anke Tönjes43, Jenny van Dongen11, Maarten van Iterson4, Joyce van Meurs48, Jan H. Veldink49, Joost Verlouw48, Peter M. Visscher28, Uwe Völker50, Urmo Võsa8,14, Harm-Jan Westra8, Cisca Wijmenga8, Hanieh Yaghootkar15, Jian Yang28,51, Biao Zeng17, Futao Zhang28
1. Computational Biology, Ontario Institute for Cancer Research, Toronto, Canada.
2. Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
3. Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
4. Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
5. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland.
6. Department of Computer Science, Johns Hopkins University, Baltimore, Maryland.
7. Heart Center Leipzig, Universität Leipzig, Leipzig, Germany.
8. Department of Genetics, University Medical Centre Groningen, Groningen, the Netherlands.
9. European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
10. Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
11. Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
12. Cardiovascular Health Research Unit, University of Washington, Seattle, Washington.
13. Genomics Coordination Center, University Medical Centre Groningen, Groningen, the Netherlands.
14. Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
15. Exeter Medical School, University of Exeter, Exeter, United Kingdom.
16. Department of Medicine, University of Washington, Seattle, Washington.
17. School of Biological Sciences, Georgia Tech, Atlanta, Georgia.
18. MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
19. Department of Psychiatry and Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
20. Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
21. Centre for Life Course Health Research, University of Oulu, Oulu, Finland.
22. Genetics and Genomic Science Department, Icahn School of Medicine at Mount Sinai, New York, New York.
23. Institut für Medizinische Informatik, Statistik und Epidemiologie, LIFE – Leipzig Research Center for Civilization Diseases, Universität Leipzig, Leipzig, Germany.
24. IFB Adiposity Diseases, Universität Leipzig, Leipzig, Germany.
25. Interdisciplinary Center for Clinical Research, Faculty of Medicine, Universität Leipzig, Leipzig, Germany.
26. Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.
27. Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
28. Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.
29. Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
30. IBE, Faculty of Medicine, Ludwig-Maximilians-University, München, Germany.
31. Department of Internal Medicine I (Cardiology), Hospital of the Ludwig-Maximilians-University Munich, München, Germany
32. Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
33. DZHK (German Centre for Cardiovascular Research), partner site Greifswald, University Medicine Greifswald, Greifswald, Germany
34. National Institute for Health and Welfare, University of Helsinki, Helsinki, Finland.
35. Garvan Institute of Medical Research, Garvan-Weizmann Centre for Cellular Genomics, Sydney, Australia.
36. Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
37. Institute of Human Genetics, Technical University Munich, Munich, Germany.
38. Departments of Epidemiology, Medicine, and Health Services, University of Washington, Seattle, Washington.
39. Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
40. Centre for Population Health Research, Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital and University of Turku, Turku, Finland.
41. Statistical and Translational Genetics, University of Helsinki, Helsinki, Finland.
42. Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
43. Department of Medicine, Universität Leipzig, Leipzig, Germany.
44. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
45. Center for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
46. Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
47. Institute for Laboratory Medicine, LIFE – Leipzig Research Center for Civilization Diseases, Universität Leipzig, Leipzig, Germany.
48. Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands.
49. Department of Neurology, University Medical Center Utrecht, Utrecht, the Netherlands.
50. Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
51. Institute for Advanced Research, Wenzhou Medical University, Wenzhou, Zhejiang, China.
BIOS Consortium (Biobank-based Integrative Omics Study):
Management Team: Bastiaan T. Heijmans (Chair)1, Peter A.C. ‘t Hoen2, Joyce van Meurs3, Aaron Isaacs4, Rick Jansen5, Lude Franke6.
Cohort Collection: Dorret I. Boomsma7, René Pool7, Jenny van Dongen7, Jouke J. Hottenga7 (Netherlands Twin Register); Marleen MJ van Greevenbroek8, Coen D.A. Stehouwer8, Carla J.H. van der Kallen8, Casper G. Schalkwijk8 (Cohort study on Diabetes and Atherosclerosis Maastricht); Cisca Wijmenga6, Lude Franke6, Sasha Zhernakova6, Ettje F. Tigchelaar6 (LifeLines Deep); P. Eline Slagboom1, Marian Beekman1, Joris Deelen1, Diana van Heemst9 (Leiden Longevity Study); Jan H. Veldink10, Leonard H. van den Berg10 (Prospective ALS Study Netherlands); Cornelia M. van Duijn4, Bert A. Hofman11, Aaron Isaacs4, André G. Uitterlinden3 (Rotterdam Study).
Data Generation: Joyce van Meurs (Chair)3, P. Mila Jhamai3, Michael Verbiest3, H. Eka D.Suchiman 1, Marijn Verkerk3, Ruud van der Breggen1, Jeroen van Rooij3, Nico Lakenberg1.Data management and computational infrastructure Hailiang Mei (Chair) 12, Maarten van Iterson1, Michiel van Galen2, Jan Bot13, Daria V. Zhernakova6, Rick Jansen5, Peter van ‘t Hof12, Patrick Deelen6, Irene Nooren13, Peter A.C. ‘t Hoen2, Bastiaan T. Heijmans1, Matthijs Moed1.
Data Analysis Group: Lude Franke (Co-Chair)6, Martijn Vermaat2, Daria V. Zhernakova6, René Luijk 1, Marc Jan Bonder6, Maarten van Iterson1, Patrick Deelen6, Freerk van Dijk14, Michiel van Galen2, Wibowo Arindrarto12, Szymon M. Kielbasa15, Morris A. Swertz14, Erik. W van Zwet15, Rick Jansen5, Peter-Bram ‘t Hoen (Co-Chair)2, Bastiaan T. Heijmans (Co-Chair)1.
1. Molecular Epidemiology Section, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands.
2. Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
3. Department of Internal Medicine, ErasmusMC, Rotterdam, the Netherlands.
4. Department of Genetic Epidemiology, ErasmusMC, Rotterdam, the Netherlands.
5. Department of Psychiatry, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
6. Department of Genetics, University of Groningen, University Medical Centre Groningen,Groningen, the Netherlands.
7. Department of Biological Psychology, VU University Amsterdam, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
8. Department of Internal Medicine and School for Cardiovascular Diseases (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands.
9. Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.
10. Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.
11. Department of Epidemiology, ErasmusMC, Rotterdam, the Netherlands.
12. Sequence Analysis Support Core, Leiden University Medical Center, Leiden, the Netherlands.
13. SURFsara, Amsterdam, the Netherlands.
14. Genomics Coordination Center, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
15. Medical Statistics Section, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands.